[Effect of hexabendin on heart and liver metabolism of acutely alloxan diabetic dogs].
D000818:Animals; D001565:Benzoates / Q000494:pharmacology*; D002951:Citrates / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000378:metabolism*; D006321:Heart / Q000187:drug effects; D006885:Hydroxybutyrates / Q000378:metabolism*; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D013268:Stimulation, Chemical; D014665:Vasodilator Agents / Q000494:pharmacology*
D001565:Benzoates; D002951:Citrates; D005230:Fatty Acids, Nonesterified; D006885:Hydroxybutyrates; D014665:Vasodilator Agents
Die Wirkung von Hexobendin auf den Herz- und Leberstoffwechsel akut alloxandiabetischer Hunde.